These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16823699)

  • 41. In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface.
    André M; Chambrion C; Charrin S; Soave S; Chaker J; Boucheix C; Rubinstein E; Le Naour F
    J Proteomics; 2009 Nov; 73(1):93-102. PubMed ID: 19703604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
    Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
    Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
    Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer.
    Chien CW; Lin SC; Lai YY; Lin BW; Lin SC; Lee JC; Tsai SJ
    Clin Cancer Res; 2008 Dec; 14(24):8043-51. PubMed ID: 19073968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer.
    Al-Khater KM; Almofty S; Ravinayagam V; Alrushaid N; Rehman S
    Saudi J Biol Sci; 2021 Jun; 28(6):3391-3398. PubMed ID: 34121877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
    Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
    Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Tetraspanins in Hepatocellular Carcinoma.
    Cai S; Deng Y; Peng H; Shen J
    Front Oncol; 2021; 11():723341. PubMed ID: 34540692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.
    Vences-Catalán F; Levy S
    Front Immunol; 2018; 9():1277. PubMed ID: 29946318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor Immunity Is Controlled by Tetraspanin Proteins.
    Schaper F; van Spriel AB
    Front Immunol; 2018; 9():1185. PubMed ID: 29896201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probing the interaction of tetraspanin CD151 with integrin alpha 3 beta 1 using a panel of monoclonal antibodies with distinct reactivities toward the CD151-integrin alpha 3 beta 1 complex.
    Yamada M; Tamura Y; Sanzen N; Sato-Nishiuchi R; Hasegawa H; Ashman LK; Rubinstein E; Yáñez-Mó M; Sánchez-Madrid F; Sekiguchi K
    Biochem J; 2008 Nov; 415(3):417-27. PubMed ID: 18601653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomal tetraspanins mediate cancer metastasis by altering host microenvironment.
    Lu J; Li J; Liu S; Wang T; Ianni A; Bober E; Braun T; Xiang R; Yue S
    Oncotarget; 2017 Sep; 8(37):62803-62815. PubMed ID: 28977990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.
    Jiang L; Zhang X; Geradts J; Wei Q; Hochwald S; Xu H; Huang H
    Clin Exp Med; 2019 Aug; 19(3):377-384. PubMed ID: 31004251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.